Saudi recognises Covishield as approved vaccine for travel

As Saudi continues to open up to the world, the Saudi Arabian government has recognised Covishield as an approved Covid-19 vaccine. Following this announcement, Covishield, produced by the Serum Institute of India, joins the list of eight other approved vaccines including Pfizer BioNTech, Comirnaty, Oxford AstraZeneca, SK Bioscience, Vaxzevria, Moderna, Spikevax and Johnson & Johnson.

Travellers who are fully vaccinated with Saudi-approved vaccines are able to enter the country without having to undergo institutional quarantine. While entry into Saudi is still temporarily suspended for travellers coming or passing through India in the 14 days prior to their arrival into Saudi, the approval of Covishield is a positive development as Saudi prepares to open its borders to Indian tourists.

Indian travellers who have spent 14 days in a country that is not on the list of countries where entry is temporarily suspended immediately before entering Saudi are also permitted as long as they are fully immunised. A negative PCR test conducted no more than 72 hours before departure is a mandatory requirement in all cases.